Progress in the Development of Melanocortin Receptor Selective Ligands

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|28|3443-3479

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.28, 2004-01, pp. : 3443-3479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the development of melanocortin-4 receptor ligands

By Nozawa Dai   Chaki Shigeyuki   Nakazato Atsuro  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 4, 2008-04 ,pp. : 403-427

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Development of Subtype Selective Nicotinic Acetylcholine Receptor Ligands

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 337-348

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of Ligands Selective for the Melanocortin-3 Receptor

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1085-1097

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Ligands of the Human Melanocortin-4 Receptor

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1068-1084

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to the rational design of selective melanocortin receptor antagonists

By Hruby Victor J   Cai Minying   Nyberg Joel   Muthu Dhanasekaran  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 543-557

Informa Healthcare

Access to resources Recommend Favorite